These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38509638)

  • 1. FARS-ADL across Ataxias: Construct Validity, Sensitivity to Change, and Minimal Important Change.
    Traschütz A; Fleszar Z; Hengel H; Klockgether T; Erdlenbruch F; Falkenburger BH; Klopstock T; Öztop-Çakmak Ö; Pedroso JL; Santorelli FM; Schöls L; ; Synofzik M
    Mov Disord; 2024 Jun; 39(6):965-974. PubMed ID: 38509638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of three clinical rating scales in Friedreich ataxia (FRDA).
    Bürk K; Mälzig U; Wolf S; Heck S; Dimitriadis K; Schmitz-Hübsch T; Hering S; Lindig TM; Haug V; Timmann D; Degen I; Kruse B; Dörr JM; Ratzka S; Ivo A; Schöls L; Boesch S; Klockgether T; Klopstock T; Schulz JB
    Mov Disord; 2009 Sep; 24(12):1779-84. PubMed ID: 19562766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS): a 2 year cohort study.
    Reetz K; Dogan I; Hilgers RD; Giunti P; Mariotti C; Durr A; Boesch S; Klopstock T; de Rivera FJR; Schöls L; Klockgether T; Bürk K; Rai M; Pandolfo M; Schulz JB;
    Lancet Neurol; 2016 Dec; 15(13):1346-1354. PubMed ID: 27839651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of a Scale for the Assessment and Rating of Ataxia (SARA) in Friedreich's ataxia patients according to posturography is limited.
    Schwabova J; Maly T; Laczo J; Zumrova A; Komarek V; Musova Z; Zahalka F
    J Neurol Sci; 2014 Jun; 341(1-2):64-7. PubMed ID: 24768059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychometric Validation of the Modified Functional Scale for the Assessment and Rating of Ataxia (f-SARA) in Patients With Spinocerebellar Ataxia.
    Potashman M; Popoff E; Powell L; Mackenzie A; Beiner MW; Coric V; Schmahmann J; L'Italien G
    Cerebellum; 2024 Oct; 23(5):2095-2108. PubMed ID: 38865059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term evolution of patient-reported outcome measures in spinocerebellar ataxias.
    Jacobi H; du Montcel ST; Bauer P; Giunti P; Cook A; Labrum R; Parkinson MH; Durr A; Brice A; Charles P; Marelli C; Mariotti C; Nanetti L; Sarro L; Rakowicz M; Sulek A; Sobanska A; Schmitz-Hübsch T; Schöls L; Hengel H; Baliko L; Melegh B; Filla A; Antenora A; Infante J; Berciano J; van de Warrenburg BP; Timmann D; Szymanski S; Boesch S; Nachbauer W; Kang JS; Pandolfo M; Schulz JB; Melac AT; Diallo A; Klockgether T
    J Neurol; 2018 Sep; 265(9):2040-2051. PubMed ID: 29959555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifeature quantitative motor assessment of upper limb ataxia including drawing and reaching.
    Hermle D; Schubert R; Barallon P; Ilg W; Schüle R; Reilmann R; Synofzik M; Traschütz A
    Ann Clin Transl Neurol; 2024 May; 11(5):1097-1109. PubMed ID: 38590028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological and clinical characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS) cohort: a cross-sectional analysis of baseline data.
    Reetz K; Dogan I; Costa AS; Dafotakis M; Fedosov K; Giunti P; Parkinson MH; Sweeney MG; Mariotti C; Panzeri M; Nanetti L; Arpa J; Sanz-Gallego I; Durr A; Charles P; Boesch S; Nachbauer W; Klopstock T; Karin I; Depondt C; vom Hagen JM; Schöls L; Giordano IA; Klockgether T; Bürk K; Pandolfo M; Schulz JB
    Lancet Neurol; 2015 Feb; 14(2):174-82. PubMed ID: 25566998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evidence of interventions assessed in Friedreich ataxia: a systematic review.
    Jain P; Badgujar L; Spoorendonk J; Buesch K
    Ther Adv Rare Dis; 2022; 3():26330040221139872. PubMed ID: 37180421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS): a 4-year cohort study.
    Reetz K; Dogan I; Hilgers RD; Giunti P; Parkinson MH; Mariotti C; Nanetti L; Durr A; Ewenczyk C; Boesch S; Nachbauer W; Klopstock T; Stendel C; Rodríguez de Rivera Garrido FJ; Rummey C; Schöls L; Hayer SN; Klockgether T; Giordano I; Didszun C; Rai M; Pandolfo M; Schulz JB;
    Lancet Neurol; 2021 May; 20(5):362-372. PubMed ID: 33770527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring Friedreich ataxia: complementary features of examination and performance measures.
    Lynch DR; Farmer JM; Tsou AY; Perlman S; Subramony SH; Gomez CM; Ashizawa T; Wilmot GR; Wilson RB; Balcer LJ
    Neurology; 2006 Jun; 66(11):1711-6. PubMed ID: 16769945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Item performance of the scale for the assessment and rating of ataxia in rare and ultra-rare genetic ataxias.
    Hamdan A; Hooker AC; Chen X; Traschütz A; Schüle R; ; ; Synofzik M; Karlsson MO
    CPT Pharmacometrics Syst Pharmacol; 2024 Aug; 13(8):1327-1340. PubMed ID: 38769902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-Related Quality of Life in Patients with Spinocerebellar Ataxia: a Validation Study of the EQ-5D-3L.
    Buchholz M; Weber N; Rädke A; Faber J; Schmitz-Hübsch T; Jacobi H; Xie F; Klockgether T; Michalowsky B; ;
    Cerebellum; 2024 Jun; 23(3):1020-1030. PubMed ID: 37713052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Digital Gait Measures Capture 1-Year Progression in Early-Stage Spinocerebellar Ataxia Type 2.
    Seemann J; Daghsen L; Cazier M; Lamy JC; Welter ML; Giese MA; Synofzik M; Durr A; Ilg W; Coarelli G
    Mov Disord; 2024 May; 39(5):788-797. PubMed ID: 38419144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the reliability, responsiveness, and meaningfulness of the scale for the assessment and rating of ataxia (SARA) for lysosomal storage disorders.
    Park J; Bremova-Ertl T; Brands M; Foltan T; Gautschi M; Gissen P; Hahn A; Jones S; Arash-Kaps L; Kolnikova M; Patterson M; Perlman S; Ramaswami U; Reichmannová S; Rohrbach M; Schneider SA; Shaikh A; Sivananthan S; Synofzik M; Walterfarng M; Wibawa P; Martakis K; Manto M
    J Neurol; 2024 Oct; 271(10):6888-6902. PubMed ID: 39225743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How does performance of the Friedreich Ataxia Functional Composite compare to rating scales?
    Tai G; Yiu EM; Delatycki MB; Corben LA
    J Neurol; 2017 Aug; 264(8):1768-1776. PubMed ID: 28695363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How is disease progress in Friedreich's ataxia best measured? A study of four rating scales.
    Fahey MC; Corben L; Collins V; Churchyard AJ; Delatycki MB
    J Neurol Neurosurg Psychiatry; 2007 Apr; 78(4):411-3. PubMed ID: 17056635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Friedreich and dominant ataxias: quantitative differences in cerebellar dysfunction measurements.
    Tanguy Melac A; Mariotti C; Filipovic Pierucci A; Giunti P; Arpa J; Boesch S; Klopstock T; Müller Vom Hagen J; Klockgether T; Bürk K; Schulz JB; Reetz K; Pandolfo M; Durr A; Tezenas du Montcel S;
    J Neurol Neurosurg Psychiatry; 2018 Jun; 89(6):559-565. PubMed ID: 29279305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurological effects of high-dose idebenone in patients with Friedreich's ataxia: a randomised, placebo-controlled trial.
    Di Prospero NA; Baker A; Jeffries N; Fischbeck KH
    Lancet Neurol; 2007 Oct; 6(10):878-86. PubMed ID: 17826341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A longitudinal study of the Friedreich Ataxia Impact Scale.
    Tai G; Yiu EM; Corben LA; Delatycki MB
    J Neurol Sci; 2015 May; 352(1-2):53-7. PubMed ID: 25840637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.